Fresenius Medical Care AG
FMS
$23.87
-$0.48-1.97%
NYSE
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -2.49% | -15.25% | 433.92% | 37.18% | 27.00% |
| Total Depreciation and Amortization | -0.77% | 0.87% | -4.29% | 2.38% | -0.53% |
| Total Amortization of Deferred Charges | -- | -- | 31.05% | -- | -- |
| Total Other Non-Cash Items | 86.77% | 782.14% | 13.06% | 115.83% | 58.93% |
| Change in Net Operating Assets | 6.04% | -1.41% | -23.13% | -82.39% | 161.64% |
| Cash from Operations | 11.66% | 51.96% | 31.53% | -19.92% | 84.69% |
| Capital Expenditure | -56.62% | -42.20% | -91.93% | -23.62% | -2.11% |
| Sale of Property, Plant, and Equipment | -35.63% | -3.19% | -27.38% | 107.52% | 31.66% |
| Cash Acquisitions | 79.16% | 18.37% | -79.90% | 73.53% | -46.77% |
| Divestitures | -163.70% | -91.16% | -67.02% | 13,946.28% | -99.75% |
| Other Investing Activities | -361.27% | 5.33% | -43.51% | 93.16% | -36.69% |
| Cash from Investing | -91.72% | -70.75% | -283.18% | 73.89% | -146.44% |
| Total Debt Issued | -59.42% | 62.82% | 752.32% | 1,269.44% | 1,482.15% |
| Total Debt Repaid | -7.06% | -2.17% | 72.14% | -71.53% | -44.78% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | 4.74% | -- | -- | -- | -27.60% |
| Other Financing Activities | -71.02% | -21.20% | 52.91% | -332.94% | -81.25% |
| Cash from Financing | -1,077.02% | -242.65% | 76.42% | -153.05% | 109.98% |
| Foreign Exchange rate Adjustments | 103.00% | 190.95% | -169.18% | -39.51% | -864.99% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -127.90% | -268.11% | 285.48% | -279.18% | 944.23% |